Browse drugs

…ed in previous studies.Reference Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass red…

…d 27.5 kgCO2e, expected to be negligible with home-administered SC-IFX.Between February and May 2025, five male adolescents (median ag…

… HCT116 cells treated with Ri plus chemotherapy (5-FU 40 mg/kg; oxaliplatin 7.5 mg/kg). Tumour burden, tumour multiplicity, and apoptosis (…

… established by repeated 1.5% DSS exposure with concurrent oral LMWH treatment. Intestinal fibrosis was evaluated using histological…

… at higher rates compared to older generation machines. Reduced metoprolol requirements materially improves workflow, removing time spent …

…reported in icotrokinra treatment groups through W12.Conclusion Icotrokinra, the first-in-class targeted oral peptide that selectively bloc…

…I=Crohn’s Disease Activity Index; CSF=corticosteroid free; MIRI=Mirikizumab; mNRI=Modified Nonresponder Imputation; N=Number of Patients in…

… anti-TNF (n=37, 26%), p=0.001.In the presence of antibodies to infliximab, 25 (49%) patients immediately changed to an alternative treatm…

…meability assessment across 4 days in a prospective study. Oral indomethacin was used to induce increased small bowel permeability. Baseline…

…h (2 RCTs ; SMD 0.30, 95% CI 0.04–0.57; p=0.0256). In contrast, propranolol monotherapy was associated with shorter time to death (SMD −0.8…

…ission (IQR 95–216) and 191 µmol/L at initiation (IQR 132–271). Terlipressin was bolus in 40/49 (81.6%) and continuous infusion in 9/49 (18.…

…DB6 was conjugated to DFO or DOTA and radiolabeled with 89Zr or 177Lu. Pharmacokinetics, biodistribution, and toxicity were evaluated…